These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 3013562)
1. In vitro activity of coumermycin alone or in combination against Staphylococcus aureus and Staphylococcus epidermidis. Van der Auwera P; Klastersky J Drugs Exp Clin Res; 1986; 12(4):307-11. PubMed ID: 3013562 [TBL] [Abstract][Full Text] [Related]
2. Comparative in vitro activity of CI934, a new fluoroquinolone, alone and in combination with coumermycin, against gram-positive bacteria. van der Auwera P; Vandermies A; Grenier P; Klastersky J Drugs Exp Clin Res; 1987; 13(3):125-32. PubMed ID: 3622241 [TBL] [Abstract][Full Text] [Related]
3. Comparative in-vitro activities of teicoplanin, vancomycin, coumermycin and ciprofloxacin, alone and in combination with rifampicin or LM 427, against Staphylococcus aureus. Van der Auwera P; Joly P J Antimicrob Chemother; 1987 Mar; 19(3):313-20. PubMed ID: 3032884 [TBL] [Abstract][Full Text] [Related]
4. In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods. Jacqueline C; Caillon J; Le Mabecque V; Miegeville AF; Donnio PY; Bugnon D; Potel G J Antimicrob Chemother; 2003 Apr; 51(4):857-64. PubMed ID: 12654769 [TBL] [Abstract][Full Text] [Related]
5. In vitro activity of fosfomycin combined with rifampin, pefloxacin and imipenem against staphylococci: a study by the time-kill curve method. Quentin C; Saivin S; Lafferriere C; Noury P; Bebear C Drugs Exp Clin Res; 1987; 13(4):219-24. PubMed ID: 3476291 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the activities of coumermycin, ciprofloxacin, teicoplanin, and other non-beta-lactam antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus from various geographical locations. Aldridge KE; Janney A; Sanders CV Antimicrob Agents Chemother; 1985 Nov; 28(5):634-8. PubMed ID: 2936300 [TBL] [Abstract][Full Text] [Related]
7. Antistaphylococcal activity of teicoplanin in Riyadh, Saudi Arabia. Shibl AM; Ishag AH; Durgham SM APMIS Suppl; 1988; 3():68-70. PubMed ID: 2972301 [TBL] [Abstract][Full Text] [Related]
8. Linezolid alone and in combination with rifampicin prevents experimental vascular graft infection due to methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis. Sacar M; Sacar S; Kaleli I; Onem G; Turgut H; Goksin I; Ozcan V; Kaan Inan B; Duver H; Baltalarli A J Surg Res; 2007 May; 139(2):170-5. PubMed ID: 17292421 [TBL] [Abstract][Full Text] [Related]
9. In-vitro activity of coumermycin against methicillin-resistant staphylococci: a comparison with six other agents. Thomas MG; Lang SD J Antimicrob Chemother; 1986 Aug; 18(2):171-5. PubMed ID: 3639086 [TBL] [Abstract][Full Text] [Related]
10. Killing rate and serum bactericidal activity of oxacillin, rifampin and ciprofloxacin against Staphylococcus aureus. Moretti MV; Fiorio M; Pasticci MB; Moretti A; Baldelli F; Pauluzzi S Microbiologica; 1989 Oct; 12(4):297-306. PubMed ID: 2586332 [TBL] [Abstract][Full Text] [Related]
11. Comparative in vitro activity of coumermycin against methicillin-resistant Staphylococcus aureus. Meyers BR; Srulevitch ES; Hirschman SZ Antimicrob Agents Chemother; 1985 Nov; 28(5):706-7. PubMed ID: 3853964 [TBL] [Abstract][Full Text] [Related]
12. Comparative post-antibiotic effect of five antibiotics against ten aerobic gram-positive cocci. Drabu YJ; Blakemore PH Drugs Exp Clin Res; 1990; 16(11):557-63. PubMed ID: 2151661 [TBL] [Abstract][Full Text] [Related]
13. In vitro time-kill activities of rifalazil, alone and in combination with vancomycin, against logarithmic and stationary cultures of Staphylococcus aureus. Osburne MS; Rothstein DM; Farquhar R; Murphy CK J Antibiot (Tokyo); 2006 Feb; 59(2):80-5. PubMed ID: 16629407 [TBL] [Abstract][Full Text] [Related]
14. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus. Rose WE; Poppens PT J Antimicrob Chemother; 2009 Mar; 63(3):485-8. PubMed ID: 19109338 [TBL] [Abstract][Full Text] [Related]
15. [In vitro activity of linezolid, moxifloxacin, levofloxacin, clindamycin and rifampin, alone and in combination, against Staphylococcus aureus and Staphylococcus epidermidis]. Soriano A; Jurado A; Marco F; Almela M; Ortega M; Mensa J Rev Esp Quimioter; 2005 Jun; 18(2):168-72. PubMed ID: 16130039 [TBL] [Abstract][Full Text] [Related]
16. In vitro inhibition of coagulase-negative staphylococci by vancomycin/aminoglycoside-loaded cement spacers. Streuli JC; Exner GU; Reize CL; Merkofer C; Scott CP; Zbinden R Infection; 2006 Apr; 34(2):81-6. PubMed ID: 16703297 [TBL] [Abstract][Full Text] [Related]
17. In vitro activity of sulbactam/ampicillin and ampicillin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis. Fabbri A; Tacchella A; Belli ML; Losurdo G Chemioterapia; 1988 Oct; 7(5):306-8. PubMed ID: 3224398 [TBL] [Abstract][Full Text] [Related]
18. In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus. Sahuquillo Arce JM; Colombo Gainza E; Gil Brusola A; Ortiz Estévez R; Cantón E; Gobernado M Rev Esp Quimioter; 2006 Sep; 19(3):252-7. PubMed ID: 17099793 [TBL] [Abstract][Full Text] [Related]
19. In-vitro activity of quinupristin/dalfopristin, levofloxacin and moxifloxacin against fusidic acid and rifampicin-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA) from Malaysian hospitals. Norazah A; Lim VK; Rohani MY; Kamel AG Med J Malaysia; 2005 Oct; 60(4):411-5. PubMed ID: 16570701 [TBL] [Abstract][Full Text] [Related]
20. In vitro activity of coumermycin in comparison to other non-beta-lactam antibiotics against staphylococci, streptococci, and Clostridium difficile. Mittermayer H Chemioterapia; 1987 Jun; 6(2 Suppl):163-4. PubMed ID: 3509379 [No Abstract] [Full Text] [Related] [Next] [New Search]